Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma-Reference-Cited by-同舟云学术

Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma

Published:2018-10-29 Issue:2 Volume:74 Page:358-362
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Hui Yiang¹,Lu Shaolei¹,Wang Hai¹,Resnick Murray B.¹,Wang Yihong¹^ORCID

Affiliation:

1. Department of Pathology; Rhode Island Hospital and Lifespan Medical Center; Providence RI USA

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13731/fullpdf

Reference19 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast;Lodato;Mod. Pathol.,1990

3. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ;Bartkova;Hum. Pathol.,1990

4. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways;Buerger;J. Pathol.,1999

5. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes;Buerger;J. Pathol.,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS;American Journal of Surgical Pathology;2019-11

2. HER2 protein overexpression in non-amplified ductal carcinoma in situ : quality issue or transcription mechanisms gone awry?;Histopathology;2019-01-15